U.S. markets open in 2 hours 40 minutes
  • S&P Futures

    3,676.25
    +11.75 (+0.32%)
     
  • Dow Futures

    30,046.00
    +114.00 (+0.38%)
     
  • Nasdaq Futures

    12,510.00
    +47.75 (+0.38%)
     
  • Russell 2000 Futures

    1,856.20
    +9.00 (+0.49%)
     
  • Crude Oil

    46.33
    +0.69 (+1.51%)
     
  • Gold

    1,844.30
    +3.20 (+0.17%)
     
  • Silver

    24.36
    +0.22 (+0.92%)
     
  • EUR/USD

    1.2177
    +0.0028 (+0.23%)
     
  • 10-Yr Bond

    0.9200
    0.0000 (0.00%)
     
  • Vix

    21.05
    -0.12 (-0.57%)
     
  • GBP/USD

    1.3470
    +0.0018 (+0.13%)
     
  • USD/JPY

    103.9660
    +0.1060 (+0.10%)
     
  • BTC-USD

    19,022.62
    -234.96 (-1.22%)
     
  • CMC Crypto 200

    373.47
    -0.93 (-0.25%)
     
  • FTSE 100

    6,554.58
    +64.31 (+0.99%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call

·1 min read

OAKVILLE, ON, Nov. 3, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it will release its Q3 2020 financial results after the close on Thursday, November 12, 2020. The Company will hold a conference call on Friday, November 13, 2020 to discuss the results.

CONFERENCE CALL DETAILS

DATE:

Friday, November 13, 2020

TIME:

8:30 a.m ET

DIAL-IN:

(416) 764-8688 or (888) 390-0546

CONFERENCE ID:

46246305

REPLAY DIAL-IN:

1 (888) 390-0541 (Playback 246305 #)

Expires November 20, 2020

Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1397006&tp_key=a8d3b9b5c2

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/November2020/03/c5419.html